benefits of combining cd38 inhibitor with 5-amino-1mq nad+ inhibition by quercetin increases NAD + levels in cells. A: CD38 as theranostic target in
CD38 as theranostic target in oncology Journal of Translational Medicine Springer Nature Link CD38: A Potential Therapeutic Target in Cardiovascular Disease Cardiovascular Drugs and Therapy Springer Nature Link Frontiers Nicotinamide N methyltransferase (NNMT): a novel therapeutic target for metabolic syndrome A systems approach to NAD+ restoration ScienceDirect Immunomodulatory properties of CD38 antibodies and their effect on anticancer efficacy in multiple myeloma Bisht 2023 Cancer Medicine Wiley Online Library
Pay in 4 interest-free payments of $6.97 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11




